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53-59, 1987.--The influence of estrous cycle and intrastriatal implants of 17beta-estradiol (17fl-estradiol). 17alpha- 
estradiol (17a-estradiol) or cholesterol on the number of footfaults made by female rats traversing a narrow suspended 
beam was investigated. Female rats made fewer footfaults on estrus than on other days of the cycle. This was true when 
testing occurred during either the light or dark phase of the light:dark cycle. Intrastriatal implants of 30% 17fl-estradiol for 6 
hours resuRed in a significant improvement in sensorimotor performance as soon as 4 hours after hormone implant and 
persisting for days. In contrast, intrastriatal implants of either 30% 17a-estradiol or cholesterol had no influence on 
performance. The extent of hormone diffusion away from the implant cannula was minimal, and the resulting concentration 
of 17/3-estradiol in the striatum was less than 10 pg/mg. It is concluded that estradioi has a direct, stereospecific effect in the 
striatum that influences performance of a skilled motor act in the female rat. 
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THE influence of  estrous cycle on reproductive and non- 
reproductive behaviors in rodents has been well established. 
Female rats show estrous cycle dependent  variation in sex- 
ual behavior [19], running wheel activity [3], and rotational 
behavior [7,35]. Many of these behaviors have been found to 
be associated with the increase in estrogen that triggers ovu- 
lation and the onset of  behavioral  estrus. For  example,  sex- 
ual behavior has been clearly demonstrated to depend on 
estrogen to activate neurons in the hypothalamus [31]. Es- 
trogen is also implicated in the modulation of  many non- 
reproductive behaviors.  However ,  the neural site(s) of the 
estrogenic effects on non-reproductive behaviors are not 
well characterized. 
One brain region that has been studied as a possible site 
of  estrogen's  effect on some non-reproductive behaviors is 
the striatum. This area of the brain has been implicated by 
studies reporting estrous cycle dependent  variation in 
amphetamine-stimulated dopamine (DA) release from striatal 
tissue in vitro [5]. Furthermore,  ovariectomy attenuates the 
AMPH-stimulated release of  striatal DA and estrogen treat- 
ment reverses this effect of  ovariectomy [4,5]. In addition, 
estrogen has been reported to potentiate striatal DA turnover 
[17] and induce an increase in the number of striatal DA 
receptors [16, 21, 24, 25]. 
Behavioral indices of striatal DA activity have also been 
found to be influenced by ovarian hormones. Rotational be- 
havior, induced by electrical stimulation or amphetamine, 
shows estrous cycle dependent variation [7,35]. As was seen 
with striatal DA release, ovariectomy attenuates rotational 
behavior and estrogen treatment enhances this behavior [4, 
13, 25, 35]. Finally, intrastriatal estrogen implants have been 
shown to induce changes in postural  deviation following sys- 
temic treatment with a dopamine agonist [26]. 
A potential problem with many of  the previous studies 
investigating the effects of estrogen on DA-mediated behav- 
ior is that the behaviors are typically elicited with 
dopaminergic agonists or antagonists. This raises the 
possibility that the results are due to an interaction between 
estrogen and the drug used to induce the behavior. In the 
experiment reported here, we examine the influence of  es- 
trous cycle and intrastriatal estrogen implants on the accuracy 
of foot placement while traversing a suspended beam. 
Animals quickly learn to perform this task, and neither drugs 
nor food deprivation are necessary to induce the behavior.  
While this is a complex behavior that must involve activity in 
many brain regions in addition to the one under investigation 
here, our knowledge of basal ganglia function suggests that it 
should participate in the performance of  this behavior  (for a 
review see [29]). We present evidence that there is estrous 
cycle dependent  variation in the performance of  this sen- 
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FIG. 1. The influence ofestrous cycle and light/dark cycle on sensorimotor performance. 
Female rats were repeatedly tested 2 hours after lights-on (A) or two hours after lights-off 
(B). The mean number of footfaults made over 3 consecutive days during 4- or 5-day 
estrous cycles is graphed, bars indicate S.E.M. Note the different ranges in the scales for 
A and B. *--Significantly different from estrus (p<0.05). 
sorimotor task and that estrogen has specific effects on the 
striatum that influence performance of this task in ovariec- 
tomized female rats. 
METHOD 
Experiment I 
This experiment was conducted to examine the influence 
of  estrous cycle on sensorimotor performance in adult 
female Holtzman rats (N=9).  Animals were individually 
housed in a room maintained on a 14:10, light:dark cycle 
with food and water freely available. Vaginal smears were 
taken daily to determine stage of  estrous cycle. 
The testing apparatus consisted of a wooden beam 5 ft 
long and 0.75 in. wide, supported by two boxes, 4.5 ft apart. 
At one end there was a start box, at the other end there was a 
partially enclosed dark box that the rat entered when it 
reached the end of  the beam. The behavior was initially 
shaped using chocolate chip cookie mash for reward. After 
the rats had leamed the task, the experimenter painted the 
rats'  feet with a nontoxic tempura paint before each trial. 
The rat was placed in the start box behind a line marked on 
the beam. The experimenter timed the animal from when its 
front feet crossed the start line to the time it entered the dark 
box. Each rat was given two trials per  day. For  each rat there 
were 2 beams covered with plastic tape and permanently 
marked with the rat 's  number and trial number, A semi- 
permanent record of each rat 's  performance was made by 
the tempura paint footprints left on the beams. One experi- 
menter scored the animal 's  performance daily, recording the 
number of footprints that extended off the top of the beam 
onto the side (footfaults). After the beams were scored, the 
paint was washed off and the beams were reused. Both the 
experimenter  conducting the behavioral trials and the one 
scoring the beams were unaware of the estrous cycle phase 
of  the animals during the testing. All testing took place 4-6 
hours after lights-on. Animals were followed over 2 weeks 
and only 4- or 5-day estrous cycles were used in the analysis. 
At the conclusion of this series of tests, animals were 
transferred to a room maintained on a reversed light:dark 
cycle. After 4 weeks to adapt to the new lighting conditions, 
animals were retrained for 2 weeks and the procedure was 
repeated with testing taking place 2-4 hours after lights-off, 
under red-light conditions. The estrous cycle was divided 
into days,  each beginning with the onset of the dark period. 
The effect of time of  day and estrous cycle on total footfaults 
(both trials combined) were analyzed by within-subjects 
analysis variance (repeated measures on time of day and 
estrous cycle phase). 
Experiment 2 
This experiment was conducted to determine whether the 
application of estrogen to the dorsal striatum could influence 
the ability of rats to traverse a suspended beam. Adult 
female Holtzman rats (housing conditions same as described 
above) were anesthetized with chloropent supplemented 
with methoxyflurane, and then animals were ovariectomized 
and also received bilateral implants of  22 gauge stainless 
steel guide cannulae aimed at the dorsal striatum. After 2 
weeks for recovery, animals were trained on the sen- 
sorimotor task described in Experiment 1. 
When performance on the task had stabilized, the effect 
of bilateral dorsal striatum application of: (1) 30% 17beta- 
estradiol (17fl-estradiol; 70% cholesterol; N=18);  (2) 30% 
17alpha-estradiol (17a-estradiol; N=10); or (3) cholesterol 
(N= 17) on sensorimotor performance was examined. The 
crystalline injection/implant cannulae containing 30% 17/3- 
estradiol or 17a-estradiol were prepared by mixing the ap- 
propriate amounts of estradiol with cholesterol,  dissolving in 
absolute ethanol and evaporating to dryness. Steroids were 
tamped into 28 gauge stainless steel cannulae and the outside 
of the cannulae were cleaned with absolute ethanol. 
On the day of the intrastriatal hormone injection, animals 
were first tested 2 hours after lights-on to determine 
baseline. Then each animal received cannulae containing one 
of the three steroid mixtures. (Stereotaxic coordinates for 
implants: 0.8 mm anterior and 2.5 mm lateral from Bregma, 
4.0 mm ventral from top of skull.) Animals were retested 
30--60 min and 4 hr after insertion of  the hormone-containing 
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TABLE 1 
INFLUENCE OF ESTROUS CYCLE AND LIGHT CYCLE ON TIME 
(SEC) TO TRAVERSE A SUSPENDED BEAM 
Lighting 
Condit ions Day of  Es t rous  Cycle 
During 
Testing (N)* Proestrus Estrus Diestrus 
Lights-on (18) 2.2 _+ 0.1I 2.5 _+ 0.2 2.2 _+ 0.1 
Lights-off  (15) 4.4 _+ 0.5 3.8 _+ 0.4 4.2 _+ 0.5 
*Nine female rats  were repeatedly tested for 2 weeks .  Those  es- 
trous cycles with vaginal smears clearly confirming proestrus, estrus 
and diestrus on 3 consecutive days were used in the analysis. All 
animals contributed at least 1 estrous cycle during each of the 2 
lighting conditions. 
tTime in seconds. Mean _+ S.E.M. 
cannulae. The implanted cannulae were removed after they 
had been in place for six hr and the stylettes replaced in the 
guide cannulae. Animals were tested again four hours after 
the cannulae had been removed (ten hr post-insertion), the 
next morning (two hr after light-on: 18 hr after cannulae were 
removed), and then every 24 hours for six days. 
As in Experiment 1, both the person conducting the be- 
havioral tests and the person scoring the animals' perform- 
ance were unaware of the animals' treatment group. The 
number of footfaults that each rat made after the steroid 
implants was expressed as a percent of the baseline perform- 
ance on the implant day. The effect of hormone implants on 
sensorimotor performance was analyzed by between/within 
analysis of variance (steroid implanted x % baseline over 
time). 
After the conclusion of the experiment, the brains of 
these animals were prepared for histology, sectioned at 40 
/zm and stained with cresyl violet. Only data from animals 
with both implant cannulae positioned in the dorsal striatum 
were used in the analysis, all other were eliminated. (This 
resulted in the elimination of 2 rats from the 17/3-estradiol 
group (see Fig. 3), 2 from the cholesterol group, and 3 rats 
from the 17a-estradiol group.) 
Experiment 3 
This experiment was conducted to verify that the extent 
of spread of estradiol from the site of hormone implant in 
dorsal striatum was limited to the striatum. Ten mg of crys- 
talline 30% 17/3-estradiol were added to 1 mCi of 17/3-(6,7- 
[3H]H)-estradiol (60 Ci/mmole; Amersham Corp., Arlington 
Heights, IL) in ethanol and evaporated to dryness. The 
[3H]estradiol was tamped into 28 gauge stainless steel can- 
nulae as described for Experiment 2. Rats prepared as de- 
scribed in Experiment 2 received bilateral implants of 
[3H]estradiol. Six hours later, the cannulae were removed 
and the animals were killed by decapitation. 
The brains were rapidly removed and dissected into 1.5 
mm slabs according to the method of Heffner et al. [23]. The 
slab(s) containing the injection cannula tips were identified 
and sliced at 1.5 mm intervals on a dorsal-ventral axis and 
again medial-laterally. The cube(s) at the tip of the cannula 
were pooled with corresponding cube(s) from the contralat- 
eral side. This tissue was designated as <1.5 mm from the 
cannula tip. Only brains with cannulae that penetrated the 
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FIG. 2. The  influence of  intrastriatai implants  o f  30% 17fl-estradiol 
on sensorimotor performance. The total number of footfaults is ex- 
pressed as a percent of baseline performance. Controls received 
cannulae containing either 17a-estradiol or cholesterol. **--Four 
hours after hormone treatment, animals that had received 17fl- 
estradiol showed a significant decrease in footfaults relative to con- 
trols (/9<0.005). *--Significantly different from controls (p<0.05). 
Control substances did not differ from baseline or each other at any 
time (see text for details). 
used. The tissue taken as <1.5 mm was always exclusively 
striatum. Tissue cubes ventral, medial, and lateral (but not 
dorsal) to the ones just taken were pooled with those from 
the contralateral side (1.5-3.0 mm from tip). The remaining 
tissue was designated as >3.0 mm from tip. Tissue samples 
were placed in scintillation vials containing 1 ml absolute 
ethanol and incubated at 50 degrees C overnight. Five ml of 
ACS scintillation cocktail (Amersham Corp.) were added to 
each vial and samples were counted in a Beckman LS7500 
liquid scintillation counter. Radioactivity was corrected for 
efficiency of the counter (35-40%) to disintegrations/min and 
based on the specific activity of the [3H]estradiol mixture 
was expressed as picograms [3H]estradiol per mg tissue. 
In order to examine the variability in the amount of 
[3H]estradiol that remained in each cannula, the cannulae 
after removal from the brain were placed in 500/zl absolute 
ethanol and incubated at 50 degrees C for 1 hr. Samples were 
counted in 5 ml ACS scintillation cocktail as described 
above. The cannulae contained on the average 6.31 ng es- 
tradiol (n=18; 6.31±0.79 ng; range, 2.24-14.14 ng). 
RESULTS 
Experiment 1 
There were significant effects of estrous cycle on the 
ability of female rats to accurately traverse a narrow beam, 
F(2,16)=4.82, p =0.022 (Fig. 1). As is illustrated in Fig. 1A, 
when female rats were tested 4--6 hours after lights-on they 
made significantly fewer footfaults on estru~ than on diestrus 
(p<0.05) or proestrus (,o<0.05). This effect was observed for 
footfaults made with either the front or the back feet (data 
not shown). When the same animals were tested during 
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FIG. 3. Histological localization of cannulae tip placement for 
animals receiving implants of 17/3-estradiol. Cannulae placements 
were collapsed along a rostral-caudal gradient between 0.2-1.2 mm 
rostral to Bregma [30], both left and right cannulae positions are 
illustrated on this diagram. The bar indicates 1.0 ram. Open circles 
are used for animals that showed a 10-20% improvement in perform- 
ance 4-10 hr post-hormone application. The small open squares 
indicate animals that improved more than 20% (range=20--47%) dur- 
ing this same time period. The large squares indicate animals ex- 
cluded from the experiment (see text for more details). 
lights-off (under red-light conditions), they made signifi- 
cantly more footfaults overall than when testing occurred 
during lights-on, F(1,8)= 10.99, p=0.01.  However,  there was 
still a significant effect of estrous cycle on this task. Fewer  
footfaults were made during estrus than during diestrus 
(p<0.05). The effect of estrous cycle on sensorimotor per- 
formance was independent of the time the animals took to 
traverse the beam (runtime) as runtime did not vary with the 
estrous cycle (Table 1). However,  when animals were tested 
under red-light conditions runtime was significantly greater 
than when testing occurred with the lights on 09<0.001; 
Table 1). 
Experiment 2 
There was no effect of cholesterol (N=15) or 17c~- 
estradiol (N=7) implants in the dorsal striatum on the total 
number of footfaults (percent baseline) made while travers- 
ing the beam. These groups also did not differ from each 
other, F(1,20)=0.884, so their results were pooled and desig- 
nated the control group for subsequent analyses (N=22). In 
contrast,  17/3-estradiol (N=16) implanted in the dorsal 
striatum resulted in a significant improvement in perform- 
ance within 4 hr of hormone administration (main effect of 
hormone: F(1,36)=9.69, p=0.003;  hormone × time interac- 
tion: F(8,288)= 1.998, p =0.046, Fig. 2). The decrease in foot- 
faults (percent baseline) persisted through testing 24 hr post- 
implant, reoccurred 3 days post-implant,  and then stabilized 
at the pre-implant performance rate. As was found for the 
estrous cycle, there was no effect of  intrastriatal hormone 
application on runtime. 
The placement of cannulae tips for all animals that re- 
ceived 17/~-estradiol is illustrated in Fig. 3. All animals in- 
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FIG. 4. Concentration of 17/~-estradiol (pg/mg) in tissue after dorsal 
striatum implants. The hatched bar indicates concentration of es- 
tradiol in striatum > 1.5 mm from the cannula tip (S.E.M. indicated). 
Open bar indicates estradiol concentration in tissue 1.5-3.0 mm from 
cannula tip. Solid bar indicates concentration of 17/3-estradiol >3.0 
mm from cannula tip. 
cluded in the analysis had both cannulae in the dorsal-medial 
striatum. The two animals excluded each had one cannula 
outside of  the dorsal striatum. Interestingly, the animals that 
were excluded also did not experience a change in accuracy 
of foot placement following insertion of the hormone con- 
taining cannulae. The animal with both cannulae placements 
designated with a large solid square (Fig. 3) performed at 
> 100% of baseline from 1-10 hours post-hormone insertion 
and the animal with both cannulae placements designated 
with the large open squares (Fig. 3) performed at >118% of 
baseline during this same time period. 
Experiment 3 
Six hours after cannulae had been implanted in the dorsal 
striatum only 0.52---0.15% (me a n -S .E .M . )  of the 
[3H]estradiol in the cannulae had diffused out of the can- 
nulae. From this value, one can calculate that the dose deliv- 
ered during the time that the cannula was implanted was 
approximately 33 picograms. In addition, approximately 90% 
of that amount (89.4---1.7%) was found within the striatum, 
less than 1.5 mm from the cannula tip (Fig. 3). Therefore, the 
effective concentration of estradiol in the striatum achieved 
by the implants was 5.92---2.35 pe,/mg. Negligible quantities 
were found in the other areas of the brain. 
DISCUSSION 
The results indicate that estrogen can act in the dorsal 
striatum to facillitate the performance of  a task requiring the 
integration of sensory and motor information. Female rats 
make fewer footfaults during estrus than on other days of  the 
estrous cycle. The idea that this estrous cycle dependent  
intrastriatal implants of 30% 17/3-estradiol also resulted in a 
significant improvement in sensorimotor performance. This 
effect of 17/3-estradiol was due to a specific effect of  estradiol 
in the striatum, as intrastriatal implants of 17/3-estradiol or 
cholesterol did not influence the behavior and the spread of 
17/3-estradiol from the cannulae was localized within the 
striatum. 
The finding that sensorimotor performance varied with 
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the estrous cycle may be related to reports of  estrous cycle 
dependent variation in other non-reproductive behaviors. In 
particular, there is estrous cycle dependent variation in lo- 
comotor activity, exploratory behavior, running wheel ac- 
tivity, and in sensory responsiveness (for review see [3]). 
Each of  these behaviors has also been shown to increase 
following estrogen treatment [3]. In the experiments re- 
ported here, in addition to estrous cycle dependent variation 
in behavior, we also found that fewer footfaults were made 
during the testing that occurred with lights on than for testing 
during lights off. It is possible that this is related to the 
biorhythms in striatal metabolic and functional activity that 
have been reported (e.g., [6, 12, 28, 38]). Alternatively, this 
could simply reflect a greater task difficulty under the red- 
light testing condition. 
The time-course of the behavioral effect of endogenous 
estradiol fluctuations during the estrous cycle and the re- 
sponse to intrastriatal estradiol treatment are quite similar. 
During the estrous cycle, estradiol begins slowly rising dur- 
ing late diestrus, and then rises rapidly during the late morn- 
ing of  proestrus. The peak in estradiol concentrations in 
serum (for animals on a 14: I0, light:dark cycle, lights-on at 6 
a.m.) is found between 12-2 p.m. [11]. Since each phase of 
the estrous cycle was defined as beginning with the onset of 
the dark period, animals tested on proestrus were tested 
prior to the estrogen peak. Improvement in sensorimotor 
performance was found when animals were tested on estrus, 
6 or 18 hours after the endogenous estrogen peak. 
In comparison, the intrastriatal implants of  estradiol were 
in place for 6 hours, and sensorimotor performance was 
facilitated within 4 hr of initial hormone administration. The 
improvement in behavior persisted until 18 hr after hormone 
removal (24 hr after initial hormone administration). Per- 
formance had returned to baseline by the following test day 
(2 days after treatment). Therefore, the time course of  the 
initial response to intrastriatal estrogen corresponds well 
with the time course of  the effect seen during the estrous 
cycle. However, following intrastriatal estradiol there was 
also a second transient improvement in sensorimotor per- 
formance, 3 days after hormone treatment that does not have 
a correlate during the estrous cycle. There is also no time 
during the estrous cycle when the hormonal events are com- 
parable. The increase in estrogen during the estrous cycle 
triggers a complex sequence of  endocrine events that include 
(but are not limited to) ovulation as well as the secretion of 
progesterone and estrogen from the corpus luteum during 
diestrus [11]. Therefore, during the period of time when 
hormonal conditions are similar and comparisons are appro- 
priate, the behavioral response to either endogenous ovarian 
hormones or intrastriatal estradiol is a facilitation of  per- 
formance on our sensorimotor task. 
The participation of  the striatum in the modulation of  sen- 
sorimotor function in the rat has been demonstrated in a 
number of  different ways. For example, lesions of  catechol- 
amine neurons in the striatum with the neurotoxin 
6-hydroxydopamine have been shown to disrupt skilled 
forepaw reaching in response to sensory cues [18,36]. In 
these experiments the animal can still perform the motor task 
and perceive the sensory cues but is unable to assimilate the 
sensory input fast enough to modify the ongoing motor be- 
havior. In addition, it has been found that the rapid initiation 
of  forepaw movement in response to a conditioned stimulus 
is dependent on the striatal catecholaminergic system with 
even small asymmetries inducing a decrement in response 
time [39]. In the cat, the influence of  striatal lesions on walk- 
ing behavior has been studied, and in general lesions of  the 
striatum result in very few gross motor deficits [41]. How- 
ever, the authors report a "subjective lack of 'elegance, '  
'slowness'  and ' improvement'  in the every day motor activi- 
t i e s . . . "  following striatal lesions [41]. 
Another way to describe the role of the striatum in the 
integration of sensorimotor information has been suggested 
in a recent review of  this topic [29]. Rather than directly 
controlling movement, it is suggested that the basal ganglia 
functions as a sensory analyzer that filters and transduces 
incoming sensory information for use by motor systems [29]. 
Therefore, the role of the striatum in locomotion across a 
suspended beam would most likely be to facilitate the rapid, 
accurate placement of the rats'  feet on the beam through 
analysis of  sensory input. Our finding of  hormonal influences 
in the striatum on footfaults made during locomotion across 
a suspended beam also argues that the striatum is critically 
involved in modulation of  this task and that ovarian hormones 
can modulate functional activity in this neural system, 
It is not known where or how estradiol is acting in the 
striatum to induce the behavioral response reported. Sys- 
temic estrogen is known to induce changes in the firing rates 
of substantia nigra DA neurons [ 14,15] as well as in the activity 
of DA-sensitive neurons in the striatum [1]. However, 
whether the effect of  estrogen on sensorimotor performance 
is a direct effect of estrogen on striatal DA neurons has not 
been examined. Estrogen could be acting on another popu- 
lation of neurons in the striatum to indirectly influence 
dopaminergic activity. Alternatively, this behavioral re- 
sponse to intrastriatal estrogen application could be inde- 
pendent of  the striatal DA system. 
In fact, how estrogen is able to influence neuronal activity 
in the striatum is unknown. The striatum contains very few 
(if any) genomic estrogen receptors [32]. The finding that 
neither 17ct-estradiol nor cholesterol were able to induce an 
altered behavioral response indicates that the effect of  17/3- 
estradiol was not due to a nonspecific steroid effect. In addi- 
tion, the response to 17fl-estradiol was not mimicked by 
17a-estradiol, indicating that the response is stereospecific. 
These findings suggest that there may be an estrogen recep- 
tor, dissociable from the classical genome-activating steroid 
receptor, involved in the response to estrogen in the 
striatum. 
The idea that the gonadal steroid hormones may influ- 
ence cellular activity through more than one mechanism is 
not unique to striatum. For example, it has been known for 
some time that the response of the oocyte to steroids in 
amphibians is mediated by a cell surface receptor [37]. In 
mammals, the possibility of more than one type of  estrogen 
receptor is suggested by reports of differential dose- 
responses of  uterine cells to estrogen and its synthetic 
analogue diethylstilbesterol [22]. In addition, high-affinity 
membrane binding-sites for estrogen have been reported 
both in the rat uterus [33] and in the rat brain [40]. Further- 
more, estrogen can stimulate DNA synthesis in uterine cells 
that lack nucleus-associated estrogen receptors [I0]. All of 
this evidence suggests that steroid hormones may influence 
cellular activity, both in the brain and in the uterus, by more 
than one mcehanism. Elucidation of  this alternative mech- 
anism of hormone action may be important both for our un- 
derstanding of reproductive function and for our understand- 
ing of  hormonal influences on non-reproductive behaviors. 
Finally, the finding that intrastriatal estrogen can influ- 
ence an animal's sensorimotor behavior may also be of clini- 
cal relevance for the treatment of  disorders of  the basal gan- 
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glia. Fo r  example ,  a single low dose  o f  es t rad io l  can  inc rease  
l ingual  dysk ines ia  [8], whi le  ch ron ic  e s t rogen  t r e a t m e n t  re- 
duces  t a rd ive  dysk ines ia  [9,27]. T h e r e  is also cl inical  evi- 
dence  tha t  h igh es t rogen  c o n c e n t r a t i o n s  can  inf luence  basa l  
gangl ia  func t ion  in a smal l  popu la t ion  of  (normal)  w o m e n ,  by  
induc ing  chore i fo rm d isorders  dur ing  p r egnancy  (Chorea  
G r a v i d e r u m )  and /o r  in a s soc ia t ion  wi th  b i r th  con t ro l  pill use  
[2, 20, 34], E luc ida t ion  of  the  mechan i sm(s )  t h rough  which  
es t rogen  can  modula te  basa l  gangl ia  func t ion  may  faci l i ta te  
our  u n d e r s t a n d i n g  and  t r e a t m e n t  o f  these  d iseases .  
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